Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
June 13, 2025
BioNTech Announces Strategic Transaction to Acquire CureVac
BioNTech SE and CureVac N.V. recently announced they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to...
June 4, 2025
Elicio Therapeutics Secures $10 Million in Financing
Elicio Therapeutics, Inc. recently announced it has entered a $10-million senior secured promissory note with existing investor, GKCC, LLC. The...
June 3, 2025
EXECUTIVE INTERVIEW - Adare Pharma Solutions: Fast, Flexible, and Focused: The Secrets of a Successful CDMO Partnership
Steven Facer, Senior Vice President of Sales and Marketing at Adare Pharma Solutions, shares practical insights on what makes CDMO partnerships work and what can cause them to fall short.
May 14, 2025
Hovione & Firstgene Announce Strategic Collaboration to Advance Virus-Like Particle Platform for Liver Cancer
Hovione and Firstgene Life Sciences recently announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for...
May 13, 2025
Alzamend Neuro Initiates First Phase 2 Trial of AL001 “Lithium in Brain” Study
Alzamend Neuro, Inc. recently today announced the initiation of the first of five Phase 2 clinical studies of AL001, with...
May 7, 2025
SPECIAL FEATURE - PFS & Parenteral Delivery: Innovation Is Focused on Patient-Centric, Smart & Sustainable Solutions
Contributor Cindy H. Dubin speaks with several innovating companies to discuss trends in PFS as well as advancements in autoinjectors and innovations in parenteral delivery.
May 6, 2025
EXECUTIVE INTERVIEW - MediWound Ltd.: Developing a New Class of Biologic Enzymatic Therapeutic Products to Debride Wounds
Ofer Gonen, Chief Executive Officer of MediWound, discusses the company’s innovative approach to debridement.
April 24, 2025
Inmagene Reports Topline Results From Phase 2a Study of a Nondepleting Anti-OX40 Monoclonal Antibody With an Extended Half-Life in Patients With Alopecia Areata
Inmagene Biopharmaceuticals recently reports topline results from the Phase 2a trial of IMG-007 in patients with severe alopecia areata (AA)....
April 17, 2025
Ligand Subsidiary Pelthos Therapeutics to Combine With Channel Therapeutics
Ligand Pharmaceuticals Incorporated and Channel Therapeutics Corporation recently announced the signing of a definitive merger agreement to combine Ligand’s wholly...
March 18, 2025
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Curevo Vaccine recently announced the closing of a $110-million Series B round to advance development of amezosvatein, its vaccine for...
